InvestorsHub Logo
Followers 85
Posts 32570
Boards Moderated 86
Alias Born 03/22/2005

Re: enemem post# 21034

Sunday, 10/05/2008 10:39:11 PM

Sunday, October 05, 2008 10:39:11 PM

Post# of 48085
Enemem, In retrospect, with all the time that has passed, they could have just redone the 900 and 1500 mg cohorts in RD-2, plus added another 2100 mg cohort to RD-2 that tested for maintenance of analgesia. Even with those additions, they would have had that data by now.



































Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News